Kang Hyun Mi
Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
Department of Functional Genomics, Korea University of Science and Technology (UST), Daejeon 34113, Korea.
Dev Reprod. 2023 Jun;27(2):57-65. doi: 10.12717/DR.2023.27.2.57. Epub 2023 Jun 30.
Kidney disease affects a significant portion of the global population, yet effective therapies are lacking despite advancements in identifying genetic causes. This limitation can be attributed to the absence of adequate models that accurately mimic human kidney disease, hindering targeted therapeutic development. However, the emergence of human induced pluripotent stem cells (PSCs) and the development of organoids using them have opened up a way to model kidney development and disease in humans, as well as validate the effects of new drugs. To fully leverage their capabilities in these fields, it is crucial for kidney organoids to closely resemble the structure and functionality of adult human kidneys. In this review, we aim to discuss the potential of using human PSCs or adult kidney stem cell-derived kidney organoids to model genetic kidney disease and renal cancer.
肾脏疾病影响着全球相当一部分人口,尽管在确定遗传病因方面取得了进展,但仍缺乏有效的治疗方法。这一局限性可归因于缺乏能够准确模拟人类肾脏疾病的适当模型,从而阻碍了靶向治疗的开发。然而,人类诱导多能干细胞(PSC)的出现以及利用它们开发类器官,为在人类中模拟肾脏发育和疾病以及验证新药的效果开辟了一条道路。为了充分利用它们在这些领域的能力,肾脏类器官与成年人类肾脏的结构和功能紧密相似至关重要。在这篇综述中,我们旨在讨论使用人类PSC或成年肾干细胞衍生的肾脏类器官来模拟遗传性肾脏疾病和肾癌的潜力。